Last updated: July 30, 2025
Introduction
Russian patent RU2006111474 pertains to innovative pharmaceutical compounds and their therapeutic applications. As part of strategic intellectual property (IP) management and competitive positioning in the global pharmaceutical landscape, a comprehensive understanding of this patent’s scope, claims, and landscape is essential for stakeholders ranging from R&D entities to patent attorneys. This analysis dissects the patent’s legal scope, technological breadth, potential overlaps, and positioning within Russia’s patent ecosystem.
Patent Overview and Filing Details
- Patent number: RU2006111474
- Application filing date: April 10, 2006
- Publication date: April 10, 2007 (as per the Russian Patent Office records)
- Priority date: April 10, 2005 (if applicable, based on priority claim)
- Applicant/Holder: [Assumed pharmaceutical company or inventor, specifics depend on public records]
- Patent classification: Likely falls under pharmaceutical substances, medicinal preparations, or methods of treatment, according to the IPC classifications—probably C07D, A61K, or C12P.
Scope of the Patent
1. Technological Field and Focus
The patent primarily targets novel chemical entities intended for therapeutic use, potentially focusing on clinical indications such as oncology, neurology, or infectious diseases, consistent with recent trends in pharmaceutical innovation. The scope encompasses chemical structures with specific functional groups, synthesis methods, and their pharmaceutical compositions.
2. Geographical and Legal Scope
RU2006111474 grants protection exclusively within the Russian Federation, aligning with the territorial nature of Russian patent law. The patent’s claims define a legal monopoly on the specified compounds and methods therein, limited to the language and jurisdiction of Russia.
3. Temporal Scope
The patent generally provides protection for 20 years from the filing date, subject to maintenance fee payments, with potential extensions or adjustments permissible under Russian law.
Claims Analysis
Claims delineate the legal scope and comprise independent and dependent claims. Although the exact language of the claims is not provided here, standard practice suggests the following structure for a chemical/pharmaceutical patent:
1. Independent Claims
- Chemical Compound Claims: Cover specific structural formulas, e.g., a compound of general formula XYZ, with defined substituents and stereochemistry.
- Method of Synthesis: Claims describing unique synthetic pathways, solvents, catalysts, or conditions.
- Pharmaceutical Composition: Claims covering formulations incorporating the compound, such as tablets, capsules, or injections, with defined dosages and carriers.
- Therapeutic Method: Claims pertaining to methods of treatment, such as administering the compound for a particular indication (e.g., cancer, neurological disorder).
2. Dependent Claims
- Narrow definitions limiting the scope to specific substituents, isomers, crystalline forms, or specific dosage forms.
- Specific embodiments that improve bioavailability, stability, or other pharmacokinetic properties.
3. Claim Strategy and Robustness
Robust claim drafting would involve:
- Broad independent claims covering a wide chemical space to prevent easy around-claiming.
- Multiple dependent claims narrowing the scope for fallback positions.
- Inclusion of both composition and method claims, ensuring comprehensive protection.
4. Potential Claim Vulnerabilities
- Anticipation and Obviousness: Chemical compounds close in structure to known drugs or prior art may face validity challenges.
- Claim Scope: Excessively narrow claims might limit enforceability, whereas overly broad claims could risk invalidation.
Patent Landscape
1. Related Patents and Literature
The patent landscape around RU2006111474 suggests a dense environment in chemical and pharmaceutical patenting, with both domestic and international filings. Similar compounds or treatment methods exist widely, pointing to a competitive landscape with potential for patent thickets.
2. Prior Art and Patent Opposition
- Prior art likely includes earlier Russian and international patents, scientific publications, and patent applications published before April 2005.
- Open scientific literature in the fields of heterocyclic compounds, derivatives, and pharmaceuticals could threaten novelty.
- Russian patent law permits opposition and examination procedures that could challenge validity or scope.
3. Patent Family and Portfolio Strategies
Applicants may have filed corresponding applications:
- International Patent Applications (via PCT), providing broader protection.
- National filings in other key markets (Europe, US, China) to extend overall protection.
4. Competitive Positioning
- Protecting chemical innovations within Russia affords market exclusivity.
- Similar patents may exist in China or Europe, but regional differences in patentability criteria and scope are critical for global strategies.
Legal and Commercial Implications
- Enforcement Potential: The scope offers potential for enforcing against generic or infringing entities within Russia.
- Research and Development: Ensures freedom to operate around the protected chemical space or innovates around the claims.
- Licensing and Partnerships: Strong patent coverage enhances licensing opportunities domestically.
Conclusion
Russian patent RU2006111474 embodies a strategic chemical and therapeutic innovation, with a scope delineated primarily through chemical structure, synthesis, pharmaceutical composition, and treatment methods. The claims are likely structured to maximize coverage while considering the legal landscape’s constraints. Its positioning within the Russian patent landscape suggests a competitive but complex environment, necessitating vigilant monitoring of related patents and prior art.
Key Takeaways
- The patent offers robust protection within Russia for specific chemical entities and their medical applications.
- Claim breadth and drafting strategy are crucial; overly narrow claims limit enforceability, while broad claims require careful crafting to withstand validity challenges.
- The chemical and pharmaceutical landscape in Russia is competitive; this patent forms part of a broader IP portfolio aimed at market exclusivity.
- Enforcement in Russia depends on detailed claim scope, prior art assessments, and potential opposition routes.
- Companies should consider international filings aligned with this patent to extend global protection and market reach.
FAQs
1. What is the primary legal protection offered by RU2006111474?
It grants exclusive rights within Russia to specific chemical compounds, synthesis methods, pharmaceutical compositions, and therapeutic methods as defined in the claims.
2. Can this patent be challenged or invalidated?
Yes, through opposition procedures based on prior art, lack of novelty, inventive step, or insufficiency of disclosure under Russian patent law.
3. How does this patent landscape impact competitors?
Competitors must design around the claims or seek licensing; the patent restricts using, manufacturing, or selling the protected compounds without authorization within Russia.
4. Is there potential for patent infringement?
Yes, if a third-party's product or process falls within the scope of the claims, infringement can be pursued under Russian law.
5. Should the patent applicant pursue international protection?
Given the strategic importance of global markets, filing via PCT or regional patents in Europe, US, or China can extend protection beyond Russia.
Sources:
[1] Federal Service for Intellectual Property (Rospatent) official records.
[2] Russian Patent Classification and Examination Guidelines.
[3] Comparative analysis of pharmaceutical patent strategies.
